Table 2.

Biochemical parameters of participants

Parameters	Control (n = 110)	ACS baseline (n = 150)	ACS follow-up (n = 100)
Apo A-I (mg/ml)	142.1 ± 43.3	112.5 ± 27.3***	127.2 ± 36.6###
Apo B (mg/ml)	72.3 ± 22.4	83.9 ± 28.9***	62.7 ± 20.5###
Total cholesterol (mg/dl)	161.2 ± 37.1	169.3 ± 42.0	137.0 ± 39.8###
HDL-C (mg/dl)	45.4 ± 9.6	40.2 ± 7.2***	38.3 ± 9.0
LDL-C (mg/dl)	104.0 ± 25.4	107.3 ± 34.9	80.8 ± 29.3###
VLDL-C (mg/dl)	16.9 ± 7.2	20.6 ± 11.2*	15.8 ± 11.1###
TG (mg/dl)	117.3 ± 45.2	126.8 ± 67.8	134.6 ± 90.2

Data are expressed as mean ± standard deviation. ACS Acute coronary syndrome, Apo A-I Apolipoprotein A-I, Apo B Apolipoprotein B, HDL-C HDL-cholesterol, LDL-C LDL- cholesterol, VLDL-C Very Low Density lipoprotein-cholesterol, TG Triglycerides. *represents significance value for comparison between control and ACS patients. ^#represents significance value for comparison between ACS baseline and ACS follow-up patients. *p < 0.05; **p < 0.01; ***p < 0.001, ^#p < 0.05; ^##p < 0.01; ^###p < 0.001